Levine Cancer Institute Concord — Concord, North Carolina

Levine Cancer Institute Concord is a clinical research site located in Concord, North Carolina, United States 28025.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Levine Cancer Institute Concord has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Levine Cancer Institute Concord?

Levine Cancer Institute Concord has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Levine Cancer Institute Concord conducted?

Levine Cancer Institute Concord has 2 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Urothelial Carcinoma.

Is Levine Cancer Institute Concord accredited by Crixeo Health?

Levine Cancer Institute Concord has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Levine Cancer Institute Concord?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.